Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting
Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023
Sanyou launches new European offices and continues to promote global business landscape
Intensity Therapeutics’ INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas
High Schooler empowers Youth with Nonprofit “Unlimited Potential”, raises $100,000 for Sports Medicine Research and Advocacy
America’s Best Wings: Everything You Need to Know
When athletes trust ultra-tech but bogus objects
A promising treatment for early-stage breast cancer
Health: what is cupping, this cupping therapy practiced by Karim Benzema?
Study by Didier Raoult on hydroxychloroquine: the Medicines Agency will take legal action
Mother’s Day: Are you late? Here are 4 last minute gift ideas
— Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs — CAMBRIDGE, Mass., June 3, 2023...